Incidence and prognosis of meningitis due to Haemophilus influenzae, Streptococcus pneumoniae and Neisseria meningitidis in Sweden

Scandinavian Journal of Infectious Diseases

Volumn 28, Issue 3, 1996, Pages 247-252

  Berg, Stefan ^a   Trollfors, Birger ^a   Claesson, Bo A ^a   Alestig, Kjell ^a   Gothefors, Leif ^b   Hugosson, Svante ^c   Lindquist, Lars ^d   Olcén, Per ^e   Romanus, Victoria ^f   Strangert, Katherine ^g  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^c ÖREBRO MEDICAL CENTRE HOSPITAL   (Sweden)

^d Central Hospital of Örebro   (Sweden)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^g ST GÖRAN S HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BACTERIAL MENINGITIS; CHILD; CLINICAL FEATURE; FEMALE; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; INCIDENCE; INFANT; MALE; MORTALITY; NEISSERIA MENINGITIDIS; PROGNOSIS; RETROSPECTIVE STUDY; STREPTOCOCCUS PNEUMONIAE;

EID: 9544220648     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365549609027166     Document Type: Article

References (37)

1. Schlech III W, Ward JI, Band JD, Hightower A, Fraser DW, Broom CV. Bacterial meningitis in the United States, 1978 through 1981. JAMA 253: 1749-1754, 1985.
2. Trollfors B, Claesson BA, Strangert K, Taranger J. Haemophilus influenzae meningitis in Sweden 1981-1983. Arch Dis Child 62: 1220-1223, 1987.
3. Gilbert GL, Clements DA, Broughton SJ. Haemophilus influenzae type b infections in Victoria, Australia, 1985-1987. Pediatr Infect Dis J 9: 252-257, 1990.
4. Spanjaard L, Bol P, Ekker W, Zanen HC. The incidence of bacterial meningitis in the Netherlands - a comparison of three registration systems, 1977-1982. J Infect 11: 259-268, 1985.
5. Takala AK, Eskola J, Peltola H, Mäkeiä PH. Epidemiology of invasive Haemophilus influenzae type b disease among children in Finland before vaccination with Haemophilus influenzae type b conjugate vaccine. Pediatr Infect Dis J 8: 297-302, 1989.
6. Peltola H, Kilpi T, Antilla M. Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunisation with conjugate vaccines. Lancet 340: 592-594, 1992.
7. CDC. Progress toward elimination of Haemophilus influenzae type b disease among infants and children - United States, 1987-1993. MMWR 43: 144-148, 1994.
8. ACIP. Pneumococcal polysaccharide vaccine. MMWR 38: 64-76, 1989.
9. National Central Bureau of Statistics. Official statistics of Sweden. Population part 3. Stockholm: National Bureau of Statistics, 1986-1989.
10. Trollfors B. Cost benefit analysis of general vaccination against Haemophilus influenzae type b in Sweden. Scand J Infect Dis 26: 611-614, 1994.
11. Reinert P, Liwartowski A, Dabernat H, Guyot C, Boucher J, Carrere C. Epidemiology of Haemophilus influenzae type b disease in France. Vaccine 11(Suppl. 1): S38-S42, 1993.
12. Claesson B, Trollfors B, Jodal U, Rosenhall U. Incidence and prognosis of Haemophilus influenzae meningitis in children in a Swedish region. Pediatr Infect Dis J 3: 35-39, 1984.
13. Burman LÅ, Norrby R, Trollfors B. Invasive pneumococcal infections: incidence, predisposing factors, and prognosis. Rev Infect Dis 7: 133-142, 1985.
14. Bryan JP, Rodriques de Silva H, Tavares A, Rocha H, Scheid WM. Etiology and mortality of bacterial meningitis in northeastern Brazil. Rev Infect Dis 12: 128-135, 1990.
15. Cadoz M, Denis F, Diop Mar I. Etude épidémiologique des cas de méningites purulentes hospitalisés à Dakar pendant la décennie 1970-1979. Bull WHD 59: 575-584, 1981.
16. Fortnum HM, Davis AC. Epidemiology of bacterial meningitis. Arch Dis Child 68: 763-767, 1993.
17. Wenger JD, Hightower AW, Facklam RR, Gaventa S, Broome CV, Bacterial meningitis study group. Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. J Infect Dis 162: 1316-1323, 1990.
18. Hook III EW, Horton CA, Schaberg DR. Failure of intensive care unit support to influence mortality from pneumococcal bacteremia. JAMA 249: 1055-1057, 1983.
19. Mufson MA, Kruss DM, Wasil RE, Metzger WI. Capsular types and outcome of bacteremic pneumococcal disease in the antibiotic era. Arch Intern Med 134: 505-510, 1974.
20. Durand ML, Calderwood SB, Weber DJ, Miller SI, Southwick FS, Caviness VS Jr, Swartz MN. Acute bacterial meningitis in adults: a review of 493 episodes. N. Engl J Med 328: 21-28, 1993.
21. Douglas RM, Paton JC, Duncan SJ, Hansman DJ. Antibody response to pneumococcal vaccination in children younger than five years of age. J Infect Dis 148: 131-137, 1983.
22. Leinonen M, Säkkinen A, Kalliokoski R, Luotenen J, Timonen M, Mäkelä PH. Antibody response to 14 valent pneumococcal capsular polysaccharide vaccine in pre-school age children. Pediatr Infect Dis J 5: 39-44, 1986.
23. Robbins JB, Austrian R, Lee C-J, Rastogi SC, Schiffman G, Henrichsen J, Mäkelä PH, Broome CV, Facklam RR, Tiesjema RH, Parke JC Jr. Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis 148: 1135-1159, 1983.
24. Jette LP, Flamothe F, and the pneumococcus study group. Surveillance of invasive Streptococcus pneumoniae infection in Quebec, Canada, from 1984 to 1986: serotype distribution, antimicrobial susceptibility and clinical characteristics. J Clin Microbiol 27: 1-5, 1989.
25. Berg S, Trollfors B, Alestig K, Jodal U. Incidence, serogroups and case-fatality rate of invasive meningococcal infections in a Swedish region 1975-1989. Scand J Infect Dis 24: 333-338, 1992.
26. Salwén KM, Vikerfors T, Olcén P. Increased incidence of childhood bacterial meningitis. A 25-year study in a defined population in Sweden. Scand J Infect Dis 19: 1-11, 1987.
27. Peltola H. Meningococcal disease: still with us. Rev Infect Dis 5: 71-91, 1983.
28. Samuelsson S, Gustavsen S, Rønne T. Epidemiology of meningococcal disease in Denmark 1980-1988. Scand J Infect Dis 23: 723-730, 1991.
29. Lystad A, Aasen S. The epidemiology of meningococcal disease in Norway 1975-1991. NIPH Ann 14: 57-66, 1991.
30. Valmari P, Kataja M, Peltola H. Invasive Haemophilus influenzae and meningococcal infections in Finland. Scand J Infect Dis 19: 19-27, 1987.
31. Peltola H, Jónsdóttir K, Lystad A, Sievers CJ, Kallings I. Meningococcal disease in Scandinavia. Br Med J 284: 1618-1621, 1982.
32. Bjune G, Høiby EA, Grønnesby JK, Arnesen Ø, Fredriksen JH, Halstensen A, Holten E, Lindbak A-K, Nøkleby H, Rosenqvist E, Solberg LK, Closs O, Eng J, Frøholm LO, Lystad A, Bakketeig LS, Hareide B. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet 338: 1993-1996, 1991.
33. Sierra GVG, Campa HC, Varcacel NM, Garcia IL, Izquierdo PL, Sotolongo PF, Casaneuva GV, Rico CO, Rodriguez CR, Terry MH. Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba. NIPH Ann 14: 195-207, 1991.
34. Cassio de Moares J, Perkins BA, Camargo MCC, Hidalgo NTR, Barbosa HA, Sacchi CT, Gral IML, Gattas VL, Vasconcelos H de G, Plikaytis BD, Wenger JD, Broome CV. Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil. Lancet 340: 1074-1078, 1992.
35. Reingold AL, Broome CV, Hightower AW, Ajello GW, Bolan GA, Adamsbaum C, Jones EE, Phillips C, Tiendrebeogo H, Yada A. Age-specific difference in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine. Lancet 114-118, 1985.
36. Lepow ML, Goldschneider I, Gold R, Randolph M, Gotschlich EC. Persistence of antibody following immunization of children with groups A and C meningococcal polysaccharide vaccines. Pediatrics 60: 673-680, 1977.
37. Ceesay SJ, Allen SJ, Menon A, Todd JE, Cham K, Carlone GM, Turner SH, Gheesling LL, DeWitt W, Plikaytis BD, Greenwood B. Decline in meningococcal antibody levels in African children 5 years after vaccination and the lack of an effect of booster immunization. J Infect Dis 167: 1212-1216, 1991.